Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats

被引:49
作者
van den Berg, MP [1 ]
Verhoef, JC [1 ]
Romeijn, SG [1 ]
Merkus, FWHM [1 ]
机构
[1] Leiden Univ, Amsterdam Ctr Drug Res, Dept Pharmaceut Technol & Biopharmaceut, NL-2300 RA Leiden, Netherlands
关键词
estradiol; progesterone; intranasal delivery; intravenous delivery; nose-cerebrospinal fluid drug transport;
D O I
10.1016/j.ejpb.2004.02.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The uptake of estradiol and progesterone into the cerebrospinal fluid (CSF) after intranasal and intravenous administration in rats was investigated. Each animal received estradiol intranasally. (40 mug/rat) and by intravenous infusion (10 mug/rat) into the jugular vein using a vascular access port. Hereafter, the same set of rats was treated with progesterone intranasally (200 mug/rat) and by intravenous infusion (104 mug/rat). Following nasal delivery, both steroid hormones reach C-max values in plasma and CSF at 15 min after administration. Intravenous infusion of estradiol and progesterone shows comparable plasma and CSF concentration-time profiles compared to the nasal route. For both hormones the AUC(CSF)/AUC(plasma) ratios (mean +/- SD) after intranasal delivery (estradiol 2.3 +/- 1.1%; progesterone 1.9 +/- 0.7%) do not differ significantly from the ratios shown after intravenous infusion (estradiol 2.0 +/- 0.6%; progesterone 2.2 +/- 0.8%). These results indicate that after nasal delivery estradiol and progesterone are rapidly absorbed into the systemic circulation, from where the non-protein bound hormones probably enter the CSF by crossing the blood-brain barrier. No extra direct nose-CSF transport could be demonstrated. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 31 条
[1]  
Anand Kumar T. C., 1974, CURR SCI, V43, P435
[2]   TRANSDERMAL ESTRADIOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE TREATMENT OF MENOPAUSAL COMPLAINTS [J].
BALFOUR, JA ;
HEEL, RC .
DRUGS, 1990, 40 (04) :561-582
[3]  
BERNE RM, 1990, PRINCIPLES PHYSL, P579
[4]   Lidocaine distribution into the CNS following nasal and arterial delivery: a comparison of local sampling and microdialysis techniques [J].
Chou, KJ ;
Donovan, MD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 171 (01) :53-61
[5]  
Chou KJ, 1997, BIOPHARM DRUG DISPOS, V18, P335, DOI 10.1002/(SICI)1099-081X(199705)18:4<335::AID-BDD22>3.0.CO
[6]  
2-W
[7]   Direct nose-brain transport of benzoylecgonine following intranasal administration in rats [J].
Chow, HHS ;
Anavy, N ;
Villalobos, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) :1729-1735
[8]  
Chow HHS, 1999, J PHARM SCI, V88, P754
[9]   Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats [J].
Dahlin, M ;
Björk, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :197-205
[10]   BIOAVAILABILITY OF PROGESTERONE ENHANCED BY INTRANASAL SPRAYING [J].
DAVID, GFX ;
PURI, CP ;
KUMAR, TCA .
EXPERIENTIA, 1981, 37 (05) :533-534